Related Experiment Videos
Plasma endothelin-1 in the neonatal respiratory distress syndrome
Insights
High endothelin-1 (ET-1) levels in preterm infants with respiratory distress syndrome (RDS) may indicate disease severity but do not significantly elevate pulmonary vascular resistance. ET-1 levels correlated with oxygen needs, not directly with pulmonary artery pressure.
Area of Science:
- Neonatal Medicine
- Cardiovascular Physiology
- Respiratory Medicine
Background:
- Neonatal respiratory distress syndrome (RDS) is a common condition in preterm infants.
- Pulmonary vascular resistance (PVR) is often elevated in RDS.
- Endothelin-1 (ET-1), a potent vasoconstrictor, is implicated in cardiovascular regulation.
Purpose of the Study:
- To investigate the role of endothelin-1 (ET-1) in elevated pulmonary vascular resistance (PVR) in neonatal respiratory distress syndrome (RDS).
- To assess the correlation between plasma ET-1 concentrations and pulmonary artery pressure (PAP) in preterm infants with RDS.
Main Methods:
- Studied seven preterm infants with RDS at 2, 24, and 48 hours of age.
- Measured plasma ET-1 concentrations and systolic pulmonary artery pressure (PAP) using Doppler sonography.
- Monitored systemic blood pressure, oxygen requirements, and arterial-alveolar oxygen tension ratio.
Main Results:
- Plasma ET-1 levels were elevated in the acute phase of RDS, decreasing to normal levels by 48 hours.
- Systolic pulmonary artery pressure (PAP) decreased over the study period; systemic pressure remained stable.
- No significant correlation was found between plasma ET-1 levels and systolic PAP.
- A significant association was observed between ET-1 levels and the need for supplemental oxygen and the arterial-alveolar oxygen tension ratio.
Conclusions:
- Elevated plasma ET-1 in acute RDS reflects disease severity.
- ET-1 may not be a primary contributor to elevated pulmonary vascular resistance in neonatal RDS.
- ET-1's association with oxygenation parameters suggests a role in respiratory compromise beyond direct vascular effects.
Abstract:
In order to study the contribution of the vasoconstrictory peptide endothelin-1 (ET-1) to the elevation of the pulmonary vascular resistance in the neonatal respiratory distress syndrome (RDS) seven preterm infants were studied at 2, 24 and 48 hours of age for plasma ET-1 concentrations and systolic pulmonary artery pressure (PAP), measured by Doppler sonography. Plasma ET-1 levels were high during the first day after birth, but declined soon to normal levels thereafter. During the study period, the systolic PAP also decreased, whereas the systemic pressure remained unchanged. There were no correlations between plasma ET-1 and vascular pressures, but there was a significant association between ET-1 and the requirement of supplemental oxygen and the arterial-alveolar oxygen tension ratio. Our results thus suggest that high plasma ET-1 levels in the acute phase of RDS reflect the severity of the pulmonary disease, but may not significantly contribute to the elevation of the pulmonary vascular resistance in the RDS.